Key Takeaways Cabometyx sales grow with strong RCC demand and new NET label expansion. Zanzalintinib combo met a key endpoint in the STELLAR-303 CRC study.Q2 revenue miss and RCC competition weigh on EXEL's near-term outlook.Exelixis’ (EXEL) year-to-date performance has been good. Shares of the biotech company have gained 15.6% compared with the industry’s growth of 2.9%. While shares hit a 52-week high of $49.62 on June 23, 2025, it dipped after the company reported second-quarter results on July 28.Noneth ...

Shares of Hasbro (HAS) have been strong performers lately, with the stock up 5.8% over the past month. The stock hit a new 52-week high of $80.42 in the previous session. Hasbro has gained 43.7% since the start of the year compared to the 10.1% gain for the Zacks Consumer Discretionary sector and the 26.8% return for the Zacks Toys - Games - Hobbies industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estima ...

Analysts on Wall Street project that Amer Sports, Inc. (AS) will announce quarterly earnings of $0.02 per share in its forthcoming report, representing a decline of 60% year over year. Revenues are projected to reach $1.19 billion, increasing 19.4% from the same quarter last year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Prior to a compa ...

Oncobiologics, Inc. (OTLK) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $0.83 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -4.76%. A quarter ago, it was expected that this company would post a loss of $0.55 per share when it actually produced a loss of $0.4, delivering a surprise of +27.27%.Over the last four quarters, the company has su ...

Clene Inc. (CLNN) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compares to a loss of $1.06 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -59.18%. A quarter ago, it was expected that this company would post a loss of $1.1 per share when it actually produced a loss of $0.5, delivering a surprise of +54.55%.Over the last four quarters, the company has surpassed c ...

Core Viewpoint - Analysts project that Home Depot will report quarterly earnings of $4.71 per share, reflecting a year-over-year increase of 0.9%, with revenues expected to reach $45.51 billion, a 5.4% increase from the same quarter last year [1]. Earnings Estimates - Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, indicating a collective reconsideration by covering analysts [2]. - Revisions to earnings estimates are significant indicators for predicting potential investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Key Metrics Projections - Analysts predict that the 'Number of stores - Retail' will reach 2,353, up from 2,340 in the same quarter last year [5]. - The estimated 'Number of customer transactions - Retail' is projected to be 460.54 million, compared to 451.00 million in the same quarter last year [5]. - The 'Average ticket - Retail' is expected to be $89.92, an increase from $88.90 in the same quarter last year [6]. Stock Performance - Home Depot shares have experienced a change of +13.9% in the past month, outperforming the +3.5% move of the Zacks S&P 500 composite [6].

Have you been paying attention to shares of Douglas Dynamics (PLOW) ? Shares have been on the move with the stock up 11.4% over the past month. The stock hit a new 52-week high of $32.41 in the previous session. Douglas Dynamics has gained 36.5% since the start of the year compared to the -8.2% move for the Zacks Auto-Tires-Trucks sector and the -4.2% return for the Zacks Automotive - Replacement Parts industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surpris ...

VYNE Therapeutics Inc. (VYNE) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +43.48%. A quarter ago, it was expected that this company would post a loss of $0.29 per share when it actually produced a loss of $0.2, delivering a surprise of +31.03%.Over the last four quarters, the company ha ...

Wall Street analysts expect Medtronic (MDT) to post quarterly earnings of $1.23 per share in its upcoming report, which indicates no change from the year-ago quarter. Revenues are expected to be $8.37 billion, up 5.7% from the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Prior to a company's earnings release, it is of utmos ...

Wall Street analysts expect Premier, Inc. (PINC) to post quarterly earnings of $0.34 per share in its upcoming report, which indicates a year-over-year decline of 50.7%. Revenues are expected to be $242.42 million, down 30.8% from the year-ago quarter.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Before a company announces its earnin ...